UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy

Journal of Diabetes Research, 2022-08, Vol.2022, p.1-8

2022

Volltextzugriff (PDF)

Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti‐diabetic therapies

Diabetes, obesity & metabolism, 2019-02, Vol.21 (2), p.210-217

2019

Volltextzugriff (PDF)

Why Do Falls and Lower Limb Fractures Occur More Frequently in the Diabetic Patient and How Can They Be Prevented?

Diabetes therapy, 2020-08, Vol.11 (8), p.1687-1694

2020

Volltextzugriff (PDF)

Postprandial Hyperglycemia/Hyperlipidemia (Postprandial Dysmetabolism) Is a Cardiovascular Risk Factor

The American journal of cardiology, 2007-09, Vol.100 (5), p.899-904

2007

Volltextzugriff (PDF)

Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus

The American journal of cardiology, 2012-09, Vol.110 (6), p.826-833

2012

Volltextzugriff (PDF)

Are the Protean Effects of Pentoxifylline in the Therapy of Diabetes and Its Complications Still Relevant?

Diabetes therapy, 2021-12, Vol.12 (12), p.3025-3035

Bell, David S. H.

2021

Volltextzugriff (PDF)

Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump

Diabetes therapy, 2024-06, Vol.15 (6), p.1473-1481

2024

Volltextzugriff (PDF)

Diabetic Mononeuropathies and Diabetic Amyotrophy

Diabetes therapy, 2022-10, Vol.13 (10), p.1715-1722

Bell, David S. H.

2022

Volltextzugriff (PDF)

Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk

Diabetes therapy, 2018-06, Vol.9 (3), p.919-926

2018

Volltextzugriff (PDF)

Diabetogenic effects of cardioprotective drugs

Diabetes, obesity & metabolism, 2021-04, Vol.23 (4), p.877-885

2021

Volltextzugriff (PDF)

Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient

Diabetes therapy, 2022-05, Vol.13 (5), p.1115-1119

2022

Volltextzugriff (PDF)

Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy

Diabetes therapy, 2021-10, Vol.12 (10), p.2795-2799

2021

Volltextzugriff (PDF)

Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy

Southern medical journal (Birmingham, Ala.), 2010-03, Vol.103 (3), p.265-267

Bell, David S H

2010

Volltextzugriff (PDF)

Alcohol Consumption as a Causator and/or an Accelerator of Neuropathy in People With Diabetes Is Regularly Overlooked

Diabetes therapy, 2021-10, Vol.12 (10), p.2631-2634

2021

Volltextzugriff (PDF)

Metformin‐induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes

Diabetes, obesity & metabolism, 2022-08, Vol.24 (8), p.1423-1428

Bell, David S. H.

2022

Volltextzugriff (PDF)

Case Report: Efficient Avoidance of Hospitalization for Diabetic Ketosis Utilizing Technosphere Inhaled Insulin

Diabetes therapy, 2020-05, Vol.11 (5), p.1175-1177

2020

Volltextzugriff (PDF)

Diabetic Charcot neuroarthropathy: A threat to both limb and life

Diabetes, obesity & metabolism, 2024-10

2024

Volltextzugriff (PDF)

Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus

Mayo Clinic proceedings, 2011-02, Vol.86 (2), p.128-138

2011

Volltextzugriff (PDF)

Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications

Diabetes, obesity & metabolism, 2019-06, Vol.21 (6), p.1277-1290

2019

Volltextzugriff (PDF)

In praise of pioglitazone: An economically efficacious therapy for type 2 diabetes and other manifestations of the metabolic syndrome

Diabetes, obesity & metabolism, 2023-11, Vol.25 (11), p.3093-3102

2023

Volltextzugriff (PDF)

The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes

Diabetes, obesity & metabolism, 2024-06, Vol.26 (6), p.2046-2053

2024

Volltextzugriff (PDF)

Detecting and treating the protean manifestations of diabetic autonomic neuropathy

Diabetes, obesity & metabolism, 2023-05, Vol.25 (5), p.1162-1173

Bell, David S. H.

2023

Volltextzugriff (PDF)

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

Endocrine practice, 2017-04, Vol.23 (Suppl 2), p.1-87

2017

Volltextzugriff (PDF)

The Role of Teplizumab in Newly Diagnosed Type 1 Diabetes

Endocrine practice, 2024-10, Vol.30 (10), p.1011-1011

2024

Volltextzugriff (PDF)

Letter to the Editor Regarding “Real Practice Assessment of Persistent Symptoms After Initiation of Levothyroxine”

Endocrine practice, 2024-07, Vol.30 (7), p.697-697

Bell, David S.H.

2024

Volltextzugriff (PDF)

1 – 25 von 2.508

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.224)
Mit Volltextzugriff
(2.001)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.657)
Life Sciences & Biomedicine
(1.295)
Humans
(1.133)
Female
(586)
Male
(535)
Biological And Medical Sciences
(397)
Medical Sciences
(333)
Middle Aged
(308)
Adult
(284)
Animals
(245)
Aged
(242)
Physical Sciences
(223)
General & Internal Medicine
(218)
Risk Factors
(182)
Medicine, General & Internal
(166)
Science & Technology - Other Topics
(149)
Multidisciplinary Sciences
(138)
Pediatrics
(128)
Endocrinology & Metabolism
(121)
Genomes
(115)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(10)
... seit 90 Tagen
(31)

Menü

Weitere Dienste

Einstellungen

Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy

Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti‐diabetic therapies

Why Do Falls and Lower Limb Fractures Occur More Frequently in the Diabetic Patient and How Can They Be Prevented?

Postprandial Hyperglycemia/Hyperlipidemia (Postprandial Dysmetabolism) Is a Cardiovascular Risk Factor

Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus

Are the Protean Effects of Pentoxifylline in the Therapy of Diabetes and Its Complications Still Relevant?

Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump

Diabetic Mononeuropathies and Diabetic Amyotrophy

Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk

Diabetogenic effects of cardioprotective drugs

Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient

Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy

Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy

Alcohol Consumption as a Causator and/or an Accelerator of Neuropathy in People With Diabetes Is Regularly Overlooked

Metformin‐induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes

Case Report: Efficient Avoidance of Hospitalization for Diabetic Ketosis Utilizing Technosphere Inhaled Insulin

Diabetic Charcot neuroarthropathy: A threat to both limb and life

Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus

Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications

In praise of pioglitazone: An economically efficacious therapy for type 2 diabetes and other manifestations of the metabolic syndrome

The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes

Detecting and treating the protean manifestations of diabetic autonomic neuropathy

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

The Role of Teplizumab in Newly Diagnosed Type 1 Diabetes

Letter to the Editor Regarding “Real Practice Assessment of Persistent Symptoms After Initiation of Levothyroxine”

Suchergebnisse filtern